U.S. Physical Therapy, Inc. (USPH) Upgraded at Sidoti

Sidoti upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a neutral rating to a buy rating in a research note released on Friday, Marketbeat reports. They currently have $74.00 price objective on the stock, up from their previous price objective of $62.00.

Other analysts also recently issued research reports about the company. Zacks Investment Research raised U.S. Physical Therapy from a hold rating to a buy rating and set a $71.00 price objective on the stock in a research note on Friday, June 2nd. Jefferies Group LLC reaffirmed a hold rating and set a $63.00 price objective on shares of U.S. Physical Therapy in a research note on Friday, June 30th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $68.60.

U.S. Physical Therapy (NYSE:USPH) opened at 59.20 on Friday. The stock’s 50 day moving average price is $60.81 and its 200-day moving average price is $64.40. U.S. Physical Therapy has a one year low of $51.96 and a one year high of $78.00. The stock has a market cap of $744.80 million, a P/E ratio of 37.47 and a beta of 1.07.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.60 by $0.01. The business had revenue of $104.25 million for the quarter, compared to analyst estimates of $102.93 million. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. On average, analysts predict that U.S. Physical Therapy will post $2.13 earnings per share for the current year.

WARNING: “U.S. Physical Therapy, Inc. (USPH) Upgraded at Sidoti” was posted by Markets Daily and is the property of of Markets Daily. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.themarketsdaily.com/2017/09/11/u-s-physical-therapy-inc-usph-upgraded-at-sidoti.html.

The company also recently declared a quarterly dividend, which was paid on Friday, September 8th. Shareholders of record on Monday, August 21st were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend was Thursday, August 17th. U.S. Physical Therapy’s dividend payout ratio is 46.78%.

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 5,000 shares of U.S. Physical Therapy stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $62.00, for a total value of $310,000.00. Following the sale, the director now owns 26,422 shares of the company’s stock, valued at approximately $1,638,164. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lawrance W. Mcafee sold 3,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $62.04, for a total value of $186,120.00. The disclosure for this sale can be found here. Insiders sold a total of 13,266 shares of company stock worth $801,134 in the last three months. Company insiders own 3.10% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in USPH. BlackRock Inc. raised its stake in shares of U.S. Physical Therapy by 166,319.0% in the 1st quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock valued at $101,501,000 after purchasing an additional 1,553,419 shares during the period. Aberdeen Asset Management PLC UK raised its stake in shares of U.S. Physical Therapy by 13.4% in the 2nd quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock valued at $42,582,000 after purchasing an additional 83,253 shares during the period. Renaissance Technologies LLC raised its stake in shares of U.S. Physical Therapy by 10.4% in the 2nd quarter. Renaissance Technologies LLC now owns 668,074 shares of the company’s stock valued at $40,352,000 after purchasing an additional 63,074 shares during the period. Vanguard Group Inc. raised its stake in shares of U.S. Physical Therapy by 6.5% in the 1st quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock valued at $41,892,000 after purchasing an additional 39,290 shares during the period. Finally, Bridge City Capital LLC acquired a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at about $1,760,000. 95.50% of the stock is currently owned by hedge funds and other institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply